lymphocytic lymphoma

This is referred to as small lymphocytic lymphoma.

The earliest victim, Dan Lloyd, was struck by acute lymphocytic lymphoma in 1980.

Marginal zone lymphomas were previously included among the diffuse small lymphocytic lymphomas.

Small cell lymphocytic lymphoma (overlaps with Chronic lymphocytic leukemia)

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.

Dan Lloyd was struck in 1980 with acute lymphocytic lymphoma, but after two years of radiation therapy and chemotherapy he played in 1983 in the United States Football League.

Tsimberidou AM, Wen S, McLaughlin P, et al.: Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.

CLL is a stage of small lymphocytic lymphoma (SLL), a type of B-cell lymphoma, which presents primarily in the lymph nodes.

It is considered a rare and chronic disease and is treatable but incurable and "is most closely related to multiple myeloma, with similarities to lymphocytic lymphoma and lymphocytic leukemia."

For example, B-cell chronic lymphocytic leukemia and B-cell small lymphocytic lymphoma are simply different manifestations of the same neoplasm, as are lymphoblastic lymphomas and acute lymphocytic leukemias.

The partners, associates and staff of Lepercq, de Neuflize & Co. are profoundly saddened by the loss of Paul Lepercq, who died in Paris on February 27 of lymphocytic lymphoma.

Low- or intermediate-grade mature B-cell lymphomas, such as small lymphocytic lymphoma, MALT lymphoma, mantle cell lymphoma, myeloma, or follicular cell lymphoma, are rarely seen in children.

The lack of CD5 expression is helpful in the discrimination between SMZL and chronic lymphocytic leukemia/small lymphocytic lymphoma, and the lack of CD10 expression argues against follicular lymphoma.

Some forms of lymphoma are categorized as indolent (e.g. small lymphocytic lymphoma), compatible with a long life even without treatment, whereas other forms are aggressive (e.g. Burkitt's lymphoma), causing rapid deterioration and death.

Byrd JC, Murphy T, Howard RS, et al.: Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.

Perkins JG, Flynn JM, Howard RS, et al.: Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.

Hainsworth JD, Litchy S, Barton JH, et al.: Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.

B-cell non-Hodgkin lymphomas include Burkitt lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), diffuse large B-cell lymphoma, follicular lymphoma, immunoblastic large cell lymphoma, precursor B-lymphoblastic lymphoma, and mantle cell lymphoma.